Cargando…

Potential benefits and harms of various arterial hypertension guidelines

Detalles Bibliográficos
Autores principales:	Dorobantu, Maria, Popa-Fotea, Nicoleta-Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Controversies in Hypertension
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803034/ https://www.ncbi.nlm.nih.gov/pubmed/33447772 http://dx.doi.org/10.1016/j.ijchy.2020.100047

Ejemplares similares

Lower is better in hypertension, but how low should blood pressure be targeted?
por: Touyz, Rhian M.
Publicado: (2016)

The chaos of hypertension guidelines for chronic kidney disease patients
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2019)

Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies
por: Parati, Gianfranco, et al.
Publicado: (2011)

Familial history of hypertension as a predictor of increased arterial stiffness in normotensive offspring
por: Youssef, Ghada, et al.
Publicado: (2017)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

Most Recent Trials and Advances in Hypertension
por: Rey-Rañal, Elías Martínez, et al.
Publicado: (2022)

Hypertension : physiopathology and treatment /
Publicado: (1977)

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension
por: Grossman, Ehud
Publicado: (2013)

The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
por: Cappuccio, Francesco P
Publicado: (2020)

Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes
por: Parati, Gianfranco, et al.
Publicado: (2013)

Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients
por: Lacson, Ronilda C, et al.
Publicado: (2018)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Molecular Research in Cardiovascular Disease
por: Dorobantu, Maria, et al.
Publicado: (2021)

Association of isolated diastolic hypertension based on different guideline definitions with incident cardiovascular risk in a Chinese rural cohort
por: Zhang, Shiru, et al.
Publicado: (2021)

The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension
por: Wronski, Samantha L., et al.
Publicado: (2019)

The Continuum of Invasive Techniques for the Assessment of Intermediate Coronary Lesions
por: Popa-Fotea, Nicoleta-Monica, et al.
Publicado: (2022)

Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular–Pulmonary Arterial Coupling
por: Taran, Irina N., et al.
Publicado: (2018)

Advances in neuroscience imply that harmful experiments in dogs are unethical
por: Bailey, Jarrod, et al.
Publicado: (2018)

Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease
por: Dorobantu, Maria, et al.
Publicado: (2017)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Blood Pressure: The Lower, the Better: The con side
por: Grossman, Ehud
Publicado: (2011)

RAS Blockade for Every Diabetic Patient: Pro and Con
por: Ruilope, Luis M., et al.
Publicado: (2011)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
por: Ritz, Eberhard
Publicado: (2011)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Intolerance to Statins: Mechanisms and Management
por: Bitzur, Rafael, et al.
Publicado: (2013)

(Pro)renin Receptor and Blood Pressure Regulation: A Focus on the Central Nervous System
por: Souza, Lucas A.C., et al.
Publicado: (2022)

Hypertension Management in Emergency Departments
por: Miller, Joseph, et al.
Publicado: (2020)

Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease
por: Oprescu, Nicoleta, et al.
Publicado: (2021)

MicroRNAs in Acute ST Elevation Myocardial Infarction—A New Tool for Diagnosis and Prognosis: Therapeutic Implications
por: Scărlătescu, Alina Ioana, et al.
Publicado: (2021)

Pulmonary Hypertension in Heart Failure Patients
por: Rao, Sriram D, et al.
Publicado: (2020)

Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real‐World Survey of Physicians and Patients With Hypertension in China
por: Feldman, Ross D., et al.
Publicado: (2016)

Antihypertensive medication class and diastolic orthostatic hypertension in older Caribbean adult patients
por: Smith, Latoya, et al.
Publicado: (2023)

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
por: van Dorst, Daan C.H., et al.
Publicado: (2021)

Guidelines for reporting an fMRI study
por: Poldrack, Russell A., et al.
Publicado: (2008)

Factors associated with uncontrolled blood pressure in hypertensive Brazilians
por: Araújo, Thayza de Paula, et al.
Publicado: (2022)

Associated factors and hemodynamic characteristics of resistant hypertension in the elderly
por: Geng, Hui, et al.
Publicado: (2023)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eg3ok5cs2ji72chkdvf4sv7v36